コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 as acquired von Willebrand factor defect and angiodysplasia).
2 ulcers and erosions; 8.3%, masses; and 3.4%, angiodysplasia.
3 rsus 1.1 +/- 0.1, P < 0.001) than those with angiodysplasia.
4 peculated that LVAD support itself may cause angiodysplasia.
5 t gastrointestinal blood loss resulting from angiodysplasia.
6 an autosomal dominant disorder of localized angiodysplasia.
7 ce that LVAD support causes gastrointestinal angiodysplasia.
8 reported 17 polyps (largest size 10 mm) and angiodysplasia.
9 strointestinal bleeding and gastrointestinal angiodysplasia.
10 s and gastrointestinal bleeding secondary to angiodysplasias.
11 ing secondary to vascular lesions, including angiodysplasias.
12 6 patients (54.5%) who no longer had typical angiodysplasias.
13 an autosomal dominant disorder of localized angiodysplasia, although it is sometimes mistakenly iden
16 of treatment of upper gastrointestinal (UGI) angiodysplasia and GAVE hemorrhage by endoscopic argon p
21 g gastric antral vascular ectasia (GAVE) and angiodysplasia, are increasingly recognized as important
25 versus 5%; P=0.02) and greater frequency of angiodysplasia confirmed during endoscopy (58% versus 23
26 dy was to determine whether gastrointestinal angiodysplasia develops during continuous-flow left vent
28 s diagnosed with upper GI bleeding caused by angiodysplasia or GAVE at a tertiary hospital were recru
30 he transfusion requirements of patients with angiodysplasia-related anemia in a clinical trial settin
33 anifestation of pathological angiogenesis is angiodysplasia, vascular malformations that cause severe